Studies show that PD-1-knockout CAR-T cells exhibit approximately 3–5 times greater expansion capacity and a 60% increase in tumor clearance compared to unedited CAR-T cells in mouse leukemia models (283). Here, PDCD1 is linked to neoplasm.